Why dieting doesn't (always) work
by Sandra Aamodt · the ozempic effect: rewriting the future of weight and wellness

- health
- weight loss
- brain science
The Ozempic Surge and Shifting Wellness Conversations
Right now, Ozempic and similar medications dominate headlines as millions seek rapid weight changes without traditional calorie counting or exercise regimens. This pharmacological approach promises to rewrite personal narratives around body size and health, sparking debates about quick fixes versus deeper lifestyle shifts.
Sandra Aamodt's talk, "Why dieting doesn't (always) work," offers a brain-science lens on these trends. As a neuroscientist, she explains that traditional diets frequently fail because the brain defends a set point weight, making sustained loss difficult despite initial efforts.
How Set Point Theory Meets Pharmacological Intervention
Aamodt's core thesis centers on the brain's role in regulating weight through defended set points. Diets often trigger compensatory mechanisms that restore the original weight, underscoring why willpower alone proves insufficient for many people.
This framework both reinforces and complicates current Ozempic discussions. The drug's ability to reset appetite aligns with bypassing set-point defenses, potentially offering the sustainable reset Aamodt highlights as missing from conventional dieting. Yet her emphasis on understanding brain science for long-term wellness suggests that medication alone may not address underlying neural patterns.
- Reinforcement: Ozempic echoes Aamodt's point that external tools can interrupt the brain's weight defense.
- Complication: Reliance on drugs might overlook the sustainable practices rooted in brain awareness that Aamodt promotes.
- Reframe: The conversation shifts from blame on failed diets to exploring hybrid paths combining pharmacology with neural insights.
Weighing Quick Fixes Against Brain-Based Sustainability
Aamodt connects dieting failures directly to set-point mechanisms, positioning brain science as the path to healthier outcomes. Ozempic enters this space as a tool that could lower defended weights pharmacologically, yet it risks framing wellness as a prescription rather than an integrated understanding of appetite regulation.
Her ideas reframe the trending topic by cautioning against solutions that ignore the brain's adaptive responses. While the drug bypasses struggles noted in the talk's summary, it may still require pairing with broader strategies for enduring change.
What experiments with set-point awareness might you pursue alongside or instead of medication to test Aamodt's principles in your own wellness journey?